NCT03056391View on ClinicalTrials.gov

Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malaria

PHASE3CompletedINTERVENTIONAL

Enrollment

360

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

February 1, 2018

Study Completion Date

February 1, 2018

Conditions

Malaria

Interventions

DRUG

Paracetamol

"\>50kg: Paracetamol 1gm PO/NG 6 hourly for 72 hours (maximum dose 4g/24h) plus IV artesunate or oral artemether/lumefantrine.~\<50kg: Paracetamol 12.5-15mg/kg/dose 6 hourly for 72 hours (maximum total dose 5doses/24hours;75mg/kg) plus IV artesunate or oral artemether/lumefantrine."

Trial Locations (4)

88200

Keningau District Hospital, Keningau

Queen Elizabeth Hospital, Kota Kinabalu

89100

Kota Marudu District Hospital, Kota Marudu

89300

Ranau District Hospital, Ranau

All Listed Sponsors

lead

Menzies School of Health Research

OTHER

NCT03056391 - Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malaria | Biotech Hunter | Biotech Hunter